Fluticasone/Salmeterol (Advair Diskus Powder)
Zafirlukast (Accolate)
Albuterol Sulfate (AccuNeb Solution)
Aerosol, Metered Flunisolide (Aerobid Aerosol)
Mometasone Furoate (Asmanex Inhalent)
Budesonide
Epinephrine
Fluticasone Propionate HFA (Flovent)
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.